Lindsey Childs-Kean, Pharm.D., M.P.H., BCPS
Clinical Associate Professor
Department:
Pharmacotherapy & Translational Research
Business Phone:
(352) 273-5715
Business Email:
lchilds@ufl.edu
About Lindsey Childs-Kean
After completing her Pharm.D. from the University of Florida College of Pharmacy, Dr. Childs-Kean completed a PGY-1 residency at Tampa General Hospital in Tampa, FL, followed by a PGY-2 residency in Infectious Diseases Pharmacy at the South Texas Veterans Affairs Healthcare System in San Antonio, TX. Prior to joining UF full-time, she was the Hepatology Pharmacy Program Manager at Bay Pines VA Healthcare System in Bay Pines, FL. In that role, she established a pharmacist-led Hepatitis C clinic for patients throughout the Bay Pines System, including patients seen using Clinical Video Telehealth technology. Her professional interests include infectious diseases pharmacotherapy as well as professional development of students and new practitioners. Dr. Childs-Kean is active in many professional organizations at the state and national level, including the American Society of Health-System Pharmacists and the Florida Society of Health-System Pharmacists.
Accomplishments
Young Alumna of the Year
2018
·
Newcomb College Institute, Tulane University
Faculty Advisor of the Year
2015
·
University of Florida College of Pharmacy
Forerunner Award
2015
·
Florida Society of Health-System Pharmacists
Kevin Flannery Pharmacy Residency Scholarship
2011
·
Tampa General Hospital
Townes R. Leigh Medal for Outstanding Leadership
2010
·
University of Florida
Teaching Profile
Courses Taught
2016-2024
PHA5782C Patient Care 2: Introduction to Infectious Disease and Oncology
2016-2018,2020
PHA5163L Prac Skills Lab III
2018-2024
PHA5876C Pt Care 8 Complex Pts
2017,2019-2021,2021-2024
PHA5922 Thinking Skills
2016-2019
PHA5755 Micro, Immun, Virol
2019
PHA5605 Infectious Disease
2017-2019,2021-2024
PHA5784C Pt Care 4: GI and Renal
2015-2019
PHA5841 HIV: Challeng and Trmnt
2018
PHA5786 Travel Medicine
2015-2017
PHA5788 Pharmacotherapy 6
2014-2016
PHA5922C Thinking Skills
2014-2016
PHA5784 Pharmacotherapy 4
2015-2016
PHA5737 Drugs and Society
2015-2016
PHA5742C Pro Commun Pharm Prac
2015-2016
PHA5783 Pharmacotherapy 3
2014-2015
PHA5009 Global Health Pharm
2015
PHA5933 Select Top Pharmacy
2015
PHA5781 Pharmacotherapy 1
2015
PHA5787 Pharmacotherapy 5
2014
PHA5560C Physiol Bas Disease 1
2014
PHA5941C Intr Pha Prac Exp 1
2014
PHA5944C Intr Pha Prac Exp 4
2013
PHA5943C Intr Pha Prac Exp 3
Publications
2023
A Bundle of the Top 10 OPAT Publications in 2022.
Open forum infectious diseases.
10(6)
[DOI] 10.1093/ofid/ofad283.
[PMID] 37323428.
2023
A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion.
Therapeutic advances in infectious disease.
10
[DOI] 10.1177/20499361231191877.
[PMID] 37636216.
2023
Academic Activism: An Avenue to Action.
American journal of pharmaceutical education.
87(6)
[DOI] 10.1016/j.ajpe.2023.100080.
[PMID] 37316141.
2023
Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review.
Infectious diseases and therapy.
12(2):343-365
[DOI] 10.1007/s40121-022-00750-5.
[PMID] 36609820.
2023
Guidance for Qualitative Research Manuscripts in Pharmacy Education.
American journal of pharmaceutical education.
87(7)
[DOI] 10.1016/j.ajpe.2023.100089.
[PMID] 37380273.
2022
A Bundle of the Top 10 OPAT Publications in 2021.
Open forum infectious diseases.
9(7)
[DOI] 10.1093/ofid/ofac242.
[PMID] 35855003.
2022
Brighter horizons: The necessity of concentrated sponsorship targeted toward minoritized student pharmacists.
Journal of the American Pharmacists Association : JAPhA.
62(3):701-705
[DOI] 10.1016/j.japh.2022.03.004.
[PMID] 35367143.
2022
Does the Academy Have Trust Issues?
American journal of pharmaceutical education.
86(10)
[DOI] 10.5688/ajpe8985.
[PMID] 35169001.
2022
Pharmacy student self-assessment of strength of residency candidacy compared to clinical faculty.
Currents in pharmacy teaching & learning.
14(3):304-309
[DOI] 10.1016/j.cptl.2022.01.017.
[PMID] 35307089.
2021
A prescription for an outpatient parenteral antimicrobial therapy (OPAT) rotation for pharmacy residents
Journal of the American College of Clinical Pharmacy.
4:234-244
[DOI] 10.1002/jac5.1377.
2021
Impact of Supplemental Material Use on Student Metacognitive Monitoring and Calibration.
American journal of pharmaceutical education.
85(10)
[DOI] 10.5688/ajpe8614.
[PMID] 34400396.
2021
Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy.
Current infectious disease reports.
23(12)
[DOI] 10.1007/s11908-021-00766-x.
[PMID] 34776793.
2021
Stop tempting your students to cheat.
Currents in pharmacy teaching & learning.
13(6):588-590
[DOI] 10.1016/j.cptl.2021.01.035.
[PMID] 33867050.
2021
The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation.
Transplant infectious disease : an official journal of the Transplantation Society.
23(1)
[DOI] 10.1111/tid.13397.
[PMID] 32609940.
2021
The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders.
Hepatology (Baltimore, Md.).
74(2):566-581
[DOI] 10.1002/hep.31732.
[PMID] 33544904.
2021
The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders.
Journal of managed care & specialty pharmacy.
27(7):873-881
[DOI] 10.18553/jmcp.2021.27.7.873.
[PMID] 34185563.
2020
Doing More With Less: Review of Dolutegravir-Lamivudine, a Novel Single-Tablet Regimen for Antiretroviral-Naïve Adults With HIV-1 Infection.
The Annals of pharmacotherapy.
54(12):1252-1259
[DOI] 10.1177/1060028020933772.
[PMID] 32517480.
2020
Modification of the self-regulated strategy inventory-self report for blended and team-based learning.
Currents in pharmacy teaching & learning.
12(9):1093-1100
[DOI] 10.1016/j.cptl.2020.04.021.
[PMID] 32624138.
2020
Use of Learning Style Frameworks in Health Science Education.
American journal of pharmaceutical education.
84(7)
[DOI] 10.5688/ajpe7885.
[PMID] 32773837.
2020
Use of Personality Frameworks in Health Science Education.
American journal of pharmaceutical education.
84(8)
[DOI] 10.5688/ajpe7231.
[PMID] 32934378.
2019
All aboard!: Involvement of medical and pharmacy trainees in antimicrobial stewardship.
Infection control and hospital epidemiology.
40(2):200-205
[DOI] 10.1017/ice.2018.332.
[PMID] 30565526.
2019
Aminoglycoside Allergic Reactions.
Pharmacy (Basel, Switzerland).
7(3)
[DOI] 10.3390/pharmacy7030124.
[PMID] 31470509.
2019
Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis.
Infectious diseases and therapy.
8(4):671-686
[DOI] 10.1007/s40121-019-00259-4.
[PMID] 31392580.
2019
Fulfilling Educational Competencies through Global Pharmacy Experiences.
Pharmacy (Basel, Switzerland).
7(2)
[DOI] 10.3390/pharmacy7020050.
[PMID] 31130690.
2019
Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C.
Infection and drug resistance.
12:2259-2268
[DOI] 10.2147/IDR.S171338.
[PMID] 31413603.
2019
Relationship Between Pharmacy Students’ Use of Self-Regulated Learning Strategies and Course Outcomes.
American journal of pharmaceutical education.
83(10)
[DOI] 10.5688/ajpe7566.
[PMID] 32001890.
2018
Budgeting and determining a dues structure for a pharmacy student organization.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
75(12):856-860
[DOI] 10.2146/ajhp170258.
[PMID] 29880522.
2018
Maintaining motivation within pharmacy student organizations.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
75(17):1270-1273
[DOI] 10.2146/ajhp170557.
[PMID] 30139735.
2018
Return of the tetracyclines: omadacycline, a novel aminomethylcycline antimicrobial.
Drugs of today (Barcelona, Spain : 1998).
54(3):209-217
[DOI] 10.1358/dot.2018.54.3.2800620.
[PMID] 29771255.
2018
Sofosbuvir/Velpatasvir/Voxilaprevir: A Pan-Genotypic Direct-Acting Antiviral Combination for Hepatitis C.
The Annals of pharmacotherapy.
52(4):352-363
[DOI] 10.1177/1060028017741508.
[PMID] 29115151.
2018
Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection.
Pharmacotherapy.
38(10):1051-1057
[DOI] 10.1002/phar.2174.
[PMID] 30120841.
2017
Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.
Gastroenterology.
153(4):1165-1166
[DOI] 10.1053/j.gastro.2017.06.062.
[PMID] 28881195.
2017
Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C
Clinical Medicine Insights-Therapeutics.
9
[DOI] 10.1177/1179559X17719125.
2016
Elvitegravir for the treatment of HIV.
Expert opinion on pharmacotherapy.
17(17):2359-2370
[PMID] 27767362.
2016
Models for student organizations in multicampus schools of pharmacy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
73(16):1221-3
[DOI] 10.2146/ajhp150837.
[PMID] 27496839.
2015
ASHP Connect community.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
72(12):1002-5
[DOI] 10.2146/ajhp140524.
[PMID] 26025990.
2015
Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection.
Clinical therapeutics.
37(2):243-67
[DOI] 10.1016/j.clinthera.2014.12.012.
[PMID] 25601269.
Education
Pharm.D.
2010
·
University of Florida
M.P.H.
2006
·
University of South Florida
B.S.
2003
·
Tulane University
Contact Details
Phones:
- Business:
- (352) 273-5715
Emails:
- Business:
- lchilds@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100486
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR
HPNP 2337
GAINESVILLE FL 326103007